drug development Related News
Researchers suggest changes to haemophilia treatment
Findings from two University Hospital Bonn studies could lead to significant changes in haemophilia treatment.
Haemophilia A, which almost exclusively affects males, is the most...
Common heartburn drugs could accelerate TB treatment
Researchers have found that over-the-counter heartburn medications could shorten tuberculosis (TB) treatment.
TB typically takes months to treat, using a range of drugs. As a...
New CAR T-cell therapy offers new hope to ovarian cancer patients
CAR T-cell therapy has shown to be effective in mice with ovarian cancer, offering new hope to patients who require effective treatment.
CAR T-cell therapy...
Using AI to accelerate drug discovery
Artificial Intelligence (AI) can potentially reduce the cost and speed-up drug discovery, according to researchers at the University of Sheffield and AstraZeneca.
The new AI...
Researchers find a new drug candidate for fatty liver disease
A study from Karolinska Institutet has identified a potential antibody drug candidate for the treatment of non-alcoholic fatty liver disease.
Currently, there is no drug...
Improving migraine relief medication
Researchers from Malmö University have found a way to improve migraine relief medication by creating a shortcut from the mucous membrane in the mouth...
Researchers discover that piperlongumine can be used to treat COVID-19
Researchers have reported that the antiviral compound, piperlongumine, can be used in the treatment of COVID-19.
The researchers found that piperlongumine, a compound extracted from...
Oxford University leading research on programmable nucleic acid drugs
A consortium led by the University of Oxford researchers has been awarded £8m of funding to unlock the potential of programmable nucleic acid drugs.
Programmable...
EU regulation does not consider environmental emissions of pharmaceuticals
New research reveals that EU regulation is not currently considering the environmental emissions of pharmaceuticals in global manufacturing supply chains.
The EU regulation that covers...
A new cure for dystonia is under development
A research team in Korea have made significant steps towards finding a cure for dystonia, offering hope to thousands of musicians.
Musicians’ dystonia affects 1-3%...
UCL team gain access to the most powerful supercomputer for drug discovery
A UCL-led team of researchers are using the world’s first exascale supercomputer to identify a shortlist of potential new drugs for diseases.
The supercomputer called...
Can ketamine help treat severe alcohol disorder?
A new trial from the University of Exeter will investigate whether ketamine-assisted therapy could help treat alcohol disorder.
The £2.4 million trial will be delivered...
Promising new treatment for hand osteoarthritis in early stages
Researchers from the University of Oxford have found that the drug talarozole, which increases retinoic acid, could offer new hope for hand osteoarthritis patients.
Hand...
NICE has recommended the anti-cancer drug Enhertu for earlier use
Hundreds more people are now eligible for the breast cancer drug Enhertu as NICE recommends for use in the disease’s early stages
This means NICE...
Defence’s novel Accutox intranasal reduces 50% of cancer nodules
Defence Therapeutics, a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, has just completed a pre-clinical study using...
One in five GPs unwilling to prescribe aspirin to Lynch syndrome patients
New data finds that one in five GPs could be unwilling to prescribe aspirin to patients with Lynch syndrome, a cancer-causing condition.
A study carried...
Extracting medicinal mushrooms
As a result of the rising demand for therapeutic medications, medicinal mushrooms have become increasingly important in healthcare over the last ten years.
The rapid...
Research suggests liver disease drug could prevent COVID-19
Scientists have identified an off-patent drug that could prevent COVID-19 infection and be used to tackle future variants.
A team of scientists from the University...
Defence Therapeutics to begin phase 1 trial for new anti-cancer treatment
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the successful...
New Alzheimer’s drug Lecanemab shows promising results in trial
A new clinical trial for lecanemab reveals positive results for the future of Alzheimer’s disease treatment.
Study results presented at the 15th Clinical Trials on Alzheimer’s...
